Clinical Trials List
2021-11-01 - 2026-02-28
Phase II
Recruiting5
ICD-10N05.9
Unspecified nephritic syndrome with unspecified morphologic changes
ICD-9583.0
Nephritis and nephropathy, not specified as acute or chronic, with lesion of proliferative glomerulonephritis
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 陳奕廷 Division of Nephrology
- 許程凱 Division of Nephrology
- 許恆榮 Division of Nephrology
- Heng-Chih Pan Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- CHENG-HSU CHEN Division of Nephrology
- 吳軍毅 Division of Nephrology
- 蔡尚峰 Division of Nephrology
- TUNG-MIN YU Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Li-Yee Hong Division of Nephrology
- Cai-Mei Zheng Division of Nephrology
- I-jen Chiu Division of Nephrology
- Chia-Te Liao Division of Nephrology
- Yu-Wei Chen Division of Nephrology
- Mei-Yi Wu Division of Nephrology
- YUNG-HO HSU Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
126 participants
